|
Synonyms: HM-12525A | HM12525A | JNJ-64565111 | JNJ64565111 | LAPS-GLP-1/GCG | MK-6024 | MK6024
Compound class:
Peptide
Comment: Efinopegdutide (MK-6024, formerly HM-12525A and JNJ-64565111) is a once-weekly injectable, dual agonist of the GLP-1 and glucagon receptors [3]. Structurally is a conjugate of an oxyntomodulin analogue and the constant region (Fc) of human IgG4, joined via a 10 kDa polyethylene glycol (PEG) linker. The INN record shows that the amino acid sequence of the oxyntomodulin analogue component is HBQGTFTSDYSKYLDEKRAKEFVQWLMNTC-NH2, where B2 is 2-methylalanyl (2-aminoisobutyryl, Aib). An amide bond between E and K cyclises the peptide.
|
| Bioactivity Comments |
| We have been unable to find publicly available quantitative interaction data to support efinopegdutide agonist activity at its target GPCRs. EC50 values for adjacent analogues are provided in [6]. |
| Selectivity at GPCRs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||